A carbon nanotubes-silicon nanoparticles network for high performance lithium rechargeable battery anodes

As an effort to address the chronic capacity fading of Si anodes and thus achieve their robust cycling performance, herein, we develop a unique electrode in which silicon nanoparticles are embedded in the carbon nanotubes network. Utilizing robust contacts between silicon nanoparticles and carbon nanotubes, the composite electrodes exhibit excellent electrochemical performance : 95.5% capacity retention after 140 cycles as well as rate capability such that at the C-rate increase from 0.1C to 1C to 10C, the specific capacities of 850, 698, and 312 mAh/g are obtained, respectively. The present investigation suggests a useful design principle for silicon as well as other high capacity alloying electrodes that undergo large volume expansions during battery operations.

A Novel Thin Film Transistor Using Double Amorphous Silicon Active Layer

We have fabricated a novel low off-state leakage current thin-film transistor (TFT) using a chlorine incorporated amorphous silicon [a-Si:H(:Cl)] and amorphous silicon (a-Si:H) stacked active layer, in which conduction channel is formed in a-Si:H and a-Si:H(:Cl) is photo-insensitive material. The off-state photo-leakage current of the a-Si:H(:Cl)/a-Si:H TFT is much lower than that a conventional a-Si:H TFT

External Use of Propolis for Oral, Skin, and Genital Diseases: A Systematic Review and Meta-Analysis

Objective. The aim of this review is to provide the available evidence on the external use of propolis (EUP) for oral, skin, and genital diseases. Method. We searched twelve electronic databases for relevant studies up to June 2016. Randomized clinical trials (RCTs) were included and analysed. Results. Of the 286 articles identified, twelve potentially relevant studies met our inclusion criteria. A meta-analysis of two studies on recurrent oral aphthae (ROA) indicated that there were no significant differences in total effective rate (TER) for pain disappearance between EUP and placebo groups (RR = 1.96, 95% CI = 0.97–3.98, and P=0.06). In two studies on skin diseases, the combined treatment of EUP with other interventions revealed significant effects on the duration of treatment or TER. In one study on genital diseases, EUP showed significant differences in genital herpes outcome measures compared to placebo. Conclusions. Our results on the effectiveness of EUP for treating oral, skin, and genital diseases are not conclusive because of the low methodological qualities and small sample sizes. Further well-designed randomized controlled trials, with high quality and large samples for specific disorders, must be conducted to obtain firm conclusions